INIS
heart failure
100%
patients
76%
values
18%
biological markers
15%
exercise
15%
risks
14%
inflammation
14%
hypertension
12%
sex
12%
volume
12%
therapy
12%
levels
11%
diseases
10%
proteins
10%
strains
10%
comparative evaluations
9%
women
9%
peptides
8%
populations
8%
range
7%
reviews
7%
symptoms
6%
detection
6%
management
6%
capacity
5%
adipose tissue
5%
hazards
5%
design
5%
mortality
5%
plasma
5%
matrices
5%
interactions
5%
assessments
5%
validation
5%
fibrosis
5%
testing
5%
Keyphrases
Heart Failure with Preserved Ejection Fraction (HFpEF)
65%
Heart Failure
25%
Patients with Heart Failure
17%
Left Ventricular Ejection Fraction
15%
Preserved Ejection Fraction
15%
Diastolic Dysfunction
11%
Dilated Cardiomyopathy
10%
Left Ventricular Function
9%
Atrial Fibrillation
8%
Heart Failure Patients
8%
Echocardiographic
7%
Echocardiography
6%
Hazard Ratio
6%
Pathophysiology
6%
HFA-PEFF Score
6%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
6%
Epicardial Adipose Tissue
5%
Chronic Heart Failure
5%
Confidence Interval
5%
Medicine and Dentistry
Heart Failure
47%
Heart Failure with Preserved Ejection Fraction
41%
Ejection Fraction
18%
Heart Left Ventricle Ejection Fraction
12%
Diastolic Dysfunction
10%
Biological Marker
10%
Atrial Fibrillation
9%
Diagnosis
9%
Hemodynamic
9%
Dilated Cardiomyopathy
8%
Echocardiography
7%
Pathophysiology
6%
Cardiovascular System
6%
Cardiomyopathy
6%
Hazard Ratio
5%
Adipose Tissue
5%
Pulmonary Hypertension
5%
Cardiac Magnetic Resonance Imaging
5%
